InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Cannon Gillian. Insider active across 2 companies, notably Xenon Pharmaceuticals Inc.. Cumulatively, 4 reports have been recorded. Split: 0 buy · 1 sell. Total volume traded: €54k. Activity tracked since 4 September 2025. The latest transaction was disclosed on 5 June 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Cannon Gillian is a declarant and has filed 4 forms in total. Across the 4 recent filings we hold, sales amount to EUR 54447, over the period from 2025-09-08 to 2026-06-08. She is a Director of Xenon Pharmaceuticals Inc. and CORCEPT THERAPEUTICS INC, and the most frequent transaction nature is option exercise.